Loading...

Paul Volberding, MD

Title(s)Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-476-5470
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of MinnesotaM.D.1975
    University of ChicagoA.B.1971
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    Institute of Medicine1999Member
    American College of Physicians2015Master

    Collapse Overview 
    Collapse Overview
    I was trained in Medical Oncology but became involved in the early AIDS epidemic in San Francisco based at San Francisco General Hospital. I have worked in clinical trials in HIV-related malignancies but primarily in the development of antiretroviral therapy. I was the PI and co-director with Warner Greene of the NIAID-funded UCSF-Gladstone Center for AIDS Research supporting the large community of HIV investigators in San Francisco. CFAR provides core services, pilot grants to early career stage investigators and supports a comprehensive mentorship program. In the Clinical and Translational Sciences Institute I served as a member of the Board of Directors and formerly directed the Global Health Program. I stepped down as the Chief of the Medical Service at the San Francisco VA Medical Center in 2012 to become the Director of the UCSF AIDS Research Institute. The ARI is the comprehensive University organization that links all HIV/AIDS research programs and is the central focus for communications, media relations and philanthropic support for this internationally recognized response to the HIV epidemic. Recently, the ARI became the administrative home for a unique initiative to cure HIV infection funded by amfAR, the Foundation for AIDS Research. I serve as the Director of the amfAR Institute for HIV Cure, working with leading scientists at UCSF, the Gladstone Institute for Virology and Immunology, and the Vitalant (formerly the Blood Systems) Research Institute. I also served as the Associate Chair of the UCSF Department of Medicine for Global Health. My clinical appointment is at the VA as a retired volunteer physician where I maintain an active HIV outpatient practice. I am the Clinical Editor in Chief of the Journal of the Acquired Immunodeficiency Syndromes and served as the Chair of the Scientific Advisory Board of the Accordia Global AIDS Foundation and the Infectious Diseases Institute at Makerere University in Kampala Uganda. I was a board member of the Pangaea Global AIDS Foundation. I am an active member of the National Academy of Medicine (formerly the Institute of Medicine) of the National Academy of Sciences and am the founder and Board Chair of the International Antiviral Society-USA. On Twitter I am @pvolberding.

    Collapse Research 
    Collapse Research Activities and Funding
    Recent Advances in AIDS and HIV Research
    NIH/NIAID R13AI102630Sep 1, 2012 - Aug 31, 2022
    Role: Principal Investigator
    UCSF-Gladstone Center for AIDS Research
    NIH/NIAID P30AI027763Jul 15, 2002 - Sep 14, 2007
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH/NCI P30CA082103Aug 5, 1999 - Sep 29, 2012
    Role: Co-Investigator
    UCSF-GIVI CENTER FOR AIDS RESEARCH
    NIH/NIMH P30MH059037Sep 1, 1998 - Feb 28, 2003
    Role: Principal Investigator
    SIXTH INTERNATIONAL CONFERENCE ON AIDS
    NIH/NIAID R13AI029901Apr 1, 1990 - Mar 31, 1991
    Role: Principal Investigator
    LABORATORY AND CLINICAL STUDIES OF AIDS
    NIH/NIAID P01AI024286Feb 1, 1987 - Jun 30, 1992
    Role: Principal Investigator
    SURAMIN IN PATIENTS WITH AIDS AND AIDS RELATED ILLNESSES
    NIH/NIAID N01AI062510Dec 6, 1985
    Role: Principal Investigator
    STUDIES OF ACQUIRED IMMUNE DEFICIENCY SYNDROME
    NIH/NCI U01CA034980May 1, 1983 - Apr 30, 1987
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Sep 29, 2006
    Role: Co-Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Sep 29, 2006
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study. BMC Infect Dis. 2020 Mar 20; 20(1):238. Harding BN, Whitney BM, Nance RM, Ruderman SA, Crane HM, Burkholder G, Moore RD, Mathews WC, Eron JJ, Hunt PW, Volberding P, Rodriguez B, Mayer KH, Saag MS, Kitahata MM, Heckbert SR, Delaney JAC. PMID: 32197585.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study. BMJ Open. 2020 Mar 19; 10(3):e031487. Harding BN, Whitney BM, Nance RM, Crane HM, Burkholder G, Moore RD, Mathews WC, Eron JJ, Hunt PW, Volberding P, Rodriguez B, Mayer K, Saag MS, Kitahata MM, Heckbert SR, Delaney JAC. PMID: 32198297.
      View in: PubMed   Mentions:    Fields:    
    3. National Academies Consensus Report on Functional Assessment for Adults With Disabilities. Arch Phys Med Rehabil. 2019 12; 100(12):2407-2408. Heinemann AW, Volberding PA. PMID: 31767062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Antimicrobial Drug Development Efficiency and Surrogate Markers of Clinical Benefit. JAMA Intern Med. 2019 Nov 11. Volberding P, Chambers HF. PMID: 31710332.
      View in: PubMed   Mentions:    Fields:    
    5. Interim monitoring in a treatment strategy trial with a composite primary endpoint. Contemp Clin Trials. 2019 11; 86:105846. Kang M, Grund B, Hunsberger S, Glidden D, Volberding P. PMID: 31520741.
      View in: PubMed   Mentions:    Fields:    
    6. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial. Contemp Clin Trials. 2019 09; 84:105833. Satre DD, Anderson AN, Leibowitz AS, Levine-Hall T, Slome S, Flamm J, Hare CB, McNeely J, Weisner CM, Horberg MA, Volberding P, Silverberg MJ. PMID: 31446142.
      View in: PubMed   Mentions:    Fields:    
    7. Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial. J Gen Intern Med. 2019 10; 34(10):2054-2061. Satre DD, Leibowitz AS, Leyden W, Catz SL, Hare CB, Jang H, Lam JO, Bryant KJ, Weisner CM, Sterling SA, Horberg M, Volberding P, Silverberg MJ. PMID: 31187344.
      View in: PubMed   Mentions: 2     Fields:    
    8. HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence. JAMA. 2019 06 11; 321(22):2172-2174. Scott H, Volberding PA. PMID: 31184721.
      View in: PubMed   Mentions:    Fields:    Translation:CellsPHPublic Health
    9. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States. Open Forum Infect Dis. 2019 Jan; 6(1):ofy353. Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG. PMID: 30931346.
      View in: PubMed   Mentions:
    10. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018 11 05; 218(12):1954-1963. Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ. PMID: 30085241.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    11. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest. 2018 08 31; 128(9):4074-4085. Sharaf R, Lee GQ, Sun X, Etemad B, Aboukhater LM, Hu Z, Brumme ZL, Aga E, Bosch RJ, Wen Y, Namazi G, Gao C, Acosta EP, Gandhi RT, Jacobson JM, Skiest D, Margolis DM, Mitsuyasu R, Volberding P, Connick E, Kuritzkes DR, Lederman MM, Yu XG, Lichterfeld M, Li JZ. PMID: 30024859.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    12. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018 07 24; 320(4):379-396. Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. PMID: 30043070.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    13. Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA. J Virol. 2018 06 15; 92(12). Strongin Z, Sharaf R, VanBelzen DJ, Jacobson JM, Connick E, Volberding P, Skiest DJ, Gandhi RT, Kuritzkes DR, O'Doherty U, Li JZ. PMID: 29593048.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    14. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA. PMID: 28208122.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0180718. Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG. PMID: 28771484.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. How to Survive a Plague: The Next Great HIV/AIDS History. JAMA. 2017 04 04; 317(13):1298-1299. Volberding PA. PMID: 28384806.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    17. HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel. Top Antivir Med. 2017 Feb/Mar; 25(1):17-24. Volberding PA. PMID: 28402930.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. JAIDS: Transitions, Evolution, and Impact. J Acquir Immune Defic Syndr. 2017 01 01; 74(1):1-2. Volberding P, Blattner WA. PMID: 27926666.
      View in: PubMed   Mentions:    Fields:    
    19. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82. Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI. PMID: 27749602.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals. BMC Public Health. 2016 09 20; 16:994. Rich ZC, Chu C, Mao J, Zhou K, Cai W, Ma Q, Volberding P, Tucker JD. PMID: 27645935.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol. 2017 01; 19(1):99-108. Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL. PMID: 27576871.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Health impact of human rights testimony: harming the most vulnerable? BMJ Glob Health. 2016; 1(1):e000001. Meffert SM, Shome S, Neylan TC, Musalo K, Fineberg HV, Cooke MM, Volberding PA, Goosby EP. PMID: 28588904.
      View in: PubMed   Mentions:
    23. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2016 Jul 12; 316(2):191-210. Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. PMID: 27404187.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCellsPHPublic Health
    24. Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion. Open Forum Infect Dis. 2016 Apr; 3(2):ofw065. Chu CE, Wu F, He X, Zhou K, Cheng Y, Cai W, Geng E, Volberding P, Tucker JD. PMID: 27419150.
      View in: PubMed   Mentions:
    25. Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China. Clin Infect Dis. 2016 06 01; 62(11):1436-1442. Tang W, Han L, Best J, Zhang Y, Mollan K, Kim J, Liu F, Hudgens M, Bayus B, Terris-Prestholt F, Galler S, Yang L, Peeling R, Volberding P, Ma B, Xu H, Yang B, Huang S, Fenton K, Wei C, Tucker JD. PMID: 27129465.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    26. Building Networks for Global Clinical Research: The Basics. J Orthop Trauma. 2015 Dec; 29 Suppl 12:S15-8. Shearer DW, Volberding PA, Schemitsch EH, Cook GE, Slobogean GP, Morshed S. PMID: 26584260.
      View in: PubMed   Mentions:    Fields:    
    27. Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China. AIDS Res Hum Retroviruses. 2015 Jan; 31(1):78-84. Chu CE, Wu F, He X, Ma Q, Cheng Y, Cai W, Volberding P, Tucker JD. PMID: 25427547.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    28. Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs. Curr HIV Res. 2015; 13(3):244-9. Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, Udoh IC, Cattamanchi A, Geng EH, Volberding P. PMID: 25986374.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    29. Highlights of the 2014 International AIDS Conference: update from down under. Top Antivir Med. 2014 Dec-2015 Jan; 22(5):694-7. Volberding PA. PMID: 25612178.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Words matter: Discussing research towards an HIV cure in research and clinical contexts. J Acquir Immune Defic Syndr. 2014 Nov 01; 67(3):e110-1. Tucker JD, Volberding PA, Margolis DM, Rennie S, Barré-Sinoussi F. PMID: 25314254.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    31. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA. 2014 Jul 23-30; 312(4):410-25. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA. PMID: 25038359.
      View in: PubMed   Mentions: 170     Fields:    Translation:Humans
    32. HIV cure: the target is clearer but not yet close. Ann Intern Med. 2014 Apr 01; 160(7):505-6. Volberding P. PMID: 24424733.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    33. Solving the mystery of JAIDS. J Acquir Immune Defic Syndr. 2013 Aug 01; 63(4):417. Volberding PA. PMID: 23722609.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Bringing the end in sight: consensus regarding HIV screening strategies. Ann Intern Med. 2013 Jul 02; 159(1):63-4. Das M, Volberding P. PMID: 23698261.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    35. A chronicle of hope and promise: the world as it was, as it is, and as it can be. J Acquir Immune Defic Syndr. 2012 Aug 15; 60 Suppl 3:S49-50. El-Sadr WM, Morrison JS, Quinn T, Volberding P. PMID: 22797739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012 Jul 25; 308(4):387-402. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. PMID: 22820792.
      View in: PubMed   Mentions: 305     Fields:    Translation:Humans
    37. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 01; 60 Suppl 1:S1-18. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P. PMID: 22688010.
      View in: PubMed   Mentions: 181     Fields:    Translation:Humans
    38. The impact of HIV research on health outcome and healthcare policy. Ann Oncol. 2011 Nov; 22 Suppl 7:vii50-vii53. Volberding P. PMID: 22039146.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection. J Acquir Immune Defic Syndr. 2011 Sep 01; 58(1):1-8. Connick E, Bosch RJ, Aga E, Schlichtemeier R, Demeter LM, Volberding P. PMID: 21637110.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    40. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey. Arch Intern Med. 2011 May 09; 171(9):840-6. Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB. PMID: 21555662.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. HIV and premature aging: A field still in its infancy. Ann Intern Med. 2010 Oct 05; 153(7):477-9. Martin J, Volberding P. PMID: 20921548.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    42. Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):132-4. Dykes C, Mukherjee AL, Bosch RJ, Connick E, Volberding PA, Demeter LM. PMID: 20733405.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    43. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010 Jul 21; 304(3):321-33. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT. PMID: 20639566.
      View in: PubMed   Mentions: 291     Fields:    Translation:HumansCells
    44. Antiretroviral therapy and management of HIV infection. Lancet. 2010 Jul 03; 376(9734):49-62. Volberding PA, Deeks SG. PMID: 20609987.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    45. Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int. 2010 Sep; 78(5):478-85. Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG. PMID: 20520594.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    46. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010 Feb 09; 121(5):651-8. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. PMID: 20100969.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    47. Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS. 2009 Sep 24; 23(15):1987-95. Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E. PMID: 19696651.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    48. Cohorts, trials, and evidence: expanding our confidence in guidelines for antiretroviral resistance testing. Ann Intern Med. 2009 Jul 21; 151(2):135-6. Volberding P. PMID: 19620166.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    49. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008 Aug 06; 300(5):555-70. Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA. PMID: 18677028.
      View in: PubMed   Mentions: 330     Fields:    Translation:HumansCells
    50. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007 Dec 15; 45(12):1633-9. Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM. PMID: 18190326.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    51. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007 Nov; 18(11):2968-74. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. PMID: 17942954.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    52. The impact of HIV on chronic kidney disease outcomes. Kidney Int. 2007 Dec; 72(11):1380-7. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. PMID: 17805235.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    53. Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. Clin Infect Dis. 2007 May 15; 44(10):1375-83. Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA. PMID: 17443478.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    54. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004). J Acquir Immune Defic Syndr. 2007 Jan 01; 44(1):20-9. Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, Volberding P, Deyton L. PMID: 17091020.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    55. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006 Aug 16; 296(7):827-43. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA. PMID: 16905788.
      View in: PubMed   Mentions: 184     Fields:    Translation:HumansCells
    56. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Top HIV Med. 2006 Aug-Sep; 14(3):827-43. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA. PMID: 17016878.
      View in: PubMed   Mentions: 33     Fields:    
    57. The New York case: lessons being learned. Ann Intern Med. 2005 May 17; 142(10):866-8. Volberding PA. PMID: 15845950.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    58. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses. 2005 Mar; 21(3):200-6. Behler C, Shade S, Gregory K, Abrams D, Volberding P. PMID: 15795525.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up. Transplantation. 2004 Dec 15; 78(11):1582-9. Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST. PMID: 15591945.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    60. Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future. J Acquir Immune Defic Syndr. 2004 Oct 01; 37(2):1221-7. Henry DH, Volberding PA, Leitz G. PMID: 15385728.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004 Jul 29; 351(5):451-9. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C. PMID: 15282352.
      View in: PubMed   Mentions: 196     Fields:    Translation:HumansCellsCTClinical Trials
    62. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA. 2004 Jul 14; 292(2):251-65. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA. PMID: 15249575.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    63. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004 May 15; 38(10):1454-63. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M. PMID: 15156485.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    64. Initiating HIV therapy. Timing is critical, controversial. Postgrad Med. 2004 Feb; 115(2):15-8, 21, 24-6. Volberding PA. PMID: 15000057.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Opportunities and options for treatment research in resource-constrained settings. Clin Infect Dis. 2003 Jul 01; 37(Suppl 1):S1-3. Volberding PA. PMID: 12822126.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. HIV therapy in 2003: consensus and controversy. AIDS. 2003 Apr; 17 Suppl 1:S4-11. Volberding PA. PMID: 12870525.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    67. The pavia consensus statement. AIDS. 2003 Apr; 17 Suppl 1:S170-9. Volberding PA, Murphy RL, Barbaro G, Barbarini G, Bruno R, Cirelli A, Currie PF, Di Lorenzo G, Fantoni M, Filiced G, Galli M, Grisorio B, Moroni M, Recusani F, Sacchi P, Scevola D, Stein JH, Torre D, Vittecoq D. PMID: 12870544.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS. 2003 Mar 28; 17(5):691-8. Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM. PMID: 12646792.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsCTClinical Trials
    69. Human immunodeficiency virus hematology. Hematology Am Soc Hematol Educ Program. 2003; 294-313. Volberding PA, Baker KR, Levine AM. PMID: 14633787.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. What can modeling tell us about the threat of antiviral drug resistance? Curr Opin Infect Dis. 2002 Dec; 15(6):609-14. Blower S, Volberding P. PMID: 12821838.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    71. Adherence, resistance, and timing: current issues in the use of new therapies. AIDS Read. 2002 Aug; 12(8):349-50, 356-7, 368. Volberding P. PMID: 12229892.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2002 Jul 10; 288(2):222-35. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA. PMID: 12095387.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    73. Does hepatitis C virus infection increase the risk of HIV disease progression? JAMA. 2002 Jul 10; 288(2):241-3. Rossi SJ, Volberding PA, Wright TL. PMID: 12095390.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    74. The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res Hum Retroviruses. 2002 Jul 01; 18(10):685-93. Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A. PMID: 12167274.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCellsCTClinical Trials
    75. Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease. J Infect Dis. 2002 May 15; 185 Suppl 2:S103-4. Volberding P, Sullivan P. PMID: 12001029.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis. 2002 May 15; 185 Suppl 2:S110-4. Volberding P. PMID: 12001031.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    77. Who cares for AIDS? J Gen Intern Med. 2002 Jan; 17(1):82-3. Volberding PA. PMID: 11903780.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. HIV expertise: a roundtable. AIDS Clin Care. 2001 Sep; 13(9):79-81, 84-5. Boswell SL, Hecht FM, Powderly WG, Soloway B, Volberding PA. PMID: 11547599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Toward a definition of HIV expertise: a survey of experienced HIV physicians. AIDS Patient Care STDS. 2001 Jun; 15(6):321-30. Gerbert B, Moe JC, Saag MS, Benson CA, Jacobsen DM, Feraios A, Hill ME, Bronstone A, Caspers N, Volberding PA. PMID: 11445014.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. International perspectives on antiretroviral resistance. Introduction. J Acquir Immune Defic Syndr. 2001 Mar 01; 26 Suppl 1:S1-2. Volberding P, Lange J. PMID: 11265002.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    81. Consensus statement: anemia in HIV infection--current trends, treatment options, and practice strategies. Anemia in HIV Working Group. Clin Ther. 2000 Sep; 22(9):1004-1020; discussion 1003. Volberding P. PMID: 11048901.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    82. Looking behind: time for anal cancer screening. Am J Med. 2000 Jun 01; 108(8):674-5. Volberding P. PMID: 10856420.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    83. When and where to start: guidelines for the initiation of antiretroviral therapy. AIDS Read. 2000 Mar; 10(3):150-5; discussion 171-4. Volberding P. PMID: 10758014.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    84. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000 Jan 19; 283(3):381-90. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. PMID: 10647802.
      View in: PubMed   Mentions: 167     Fields:    Translation:HumansCells
    85. Adherence communication: a qualitative analysis of physician-patient dialogue. AIDS. 1999 Sep 10; 13(13):1771-8. Roberts KJ, Volberding P. PMID: 10509580.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    86. Advances in the medical management of patients with HIV-1 infection: an overview. AIDS. 1999 Sep; 13 Suppl 1:S1-9. Volberding PA. PMID: 10546780.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    87. Perceptions of health care professionals and patients about the risk of HIV transmission through oral sex: a qualitative study. Patient Educ Couns. 1999 Sep; 38(1):49-60. Gerbert B, Herzig K, Volberding P, Stansell J. PMID: 14528571.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. Physicians' transmission prevention assessment and counseling practices with their HIV positive patients. AIDS Educ Prev. 1999 Aug; 11(4):307-20. Gerbert B, Brown B, Volberding P, Cooke M, Caspers N, Love C, Bronstone A. PMID: 10494355.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    89. Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. J Infect Dis. 1999 Jun; 179(6):1375-81. Deeks SG, Hellmann NS, Grant RM, Parkin NT, Petropoulos CJ, Becker M, Symonds W, Chesney M, Volberding PA. PMID: 10228057.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCellsCTClinical Trials
    90. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998 Jul 01; 280(1):78-86. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. PMID: 9660368.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCellsPHPublic Health
    91. Antiretroviral therapy for HIV infection: promises and problems. JAMA. 1998 May 06; 279(17):1343-4. Volberding PA, Deeks SG. PMID: 9582033.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    92. An aggressive approach to HIV antiretroviral therapy. Hosp Pract (1995). 1998 Jan 15; 33(1):81-4, 87-90, 95-6 passim. Volberding PA. PMID: 9464233.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. HIV/AIDS. Protease inhibitors vindicated. Lancet. 1997 Dec 20-27; 350 Suppl 3:SIII10. Volberding PA. PMID: 9465186.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. Counseling patients about HIV risk from oral sex. J Gen Intern Med. 1997 Nov; 12(11):698-704. Gerbert B, Herzig K, Volberding P. PMID: 9383138.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    95. Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 01; 16(1):22-30. Ioannidis JP, Bassett R, Hughes MD, Volberding PA, Sacks HS, Lau J. PMID: 9377121.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    96. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA. 1997 Jun 25; 277(24):1962-9. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. PMID: 9200638.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    97. HIV-1 protease inhibitors. AIDS Clin Rev. 1997-1998; 145-85. Deeks SG, Volberding PA. PMID: 9305448.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    98. Medicine and HIV. Interview by David Frankel. Lancet. 1996 Oct 12; 348(9033):1007-8. Volberding PA. PMID: 8855865.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    99. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA. 1996 Jul 10; 276(2):146-54. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Sáag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. PMID: 8656507.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCellsPHPublic Health
    100. Age as a predictor of progression in HIV infection. Lancet. 1996 Jun 08; 347(9015):1569-70. Volberding PA. PMID: 8667860.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. HIV viral load markers in clinical practice. Nat Med. 1996 Jun; 2(6):625-9. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA. PMID: 8640545.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    102. Improving the outcomes of care for patients with human immunodeficiency virus infection. N Engl J Med. 1996 Mar 14; 334(11):729-31. Volberding PA. PMID: 8594437.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    103. HIV quantification: clinical applications. Lancet. 1996 Jan 13; 347(8994):71-3. Volberding PA. PMID: 8538341.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    104. Controversies in initiating anti-retroviral therapy and in the use of combination therapies. Adv Exp Med Biol. 1996; 394:333-43. Volberding PA. PMID: 8815699.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    105. Zidovudine side effects as reported by black, Hispanic, and white/non-Hispanic patients with early HIV disease: combined analysis of two multicenter placebo-controlled trials. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 01; 11(1):45-52. Jacobson MA, Gundacker H, Hughes M, Fischl M, Volberding P. PMID: 8528732.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    106. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol. 1996 Jan; 36(1):55-63. Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD. PMID: 8932544.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    107. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med. 1995 Aug 17; 333(7):401-7. Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng TC, Fischl MA, Collier AC, Phair JP, Hirsch MS. PMID: 7616988.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    108. An approach to antiretroviral treatment of HIV disease. Combined antiretroviral therapy: the emerging role. Hosp Pract (1995). 1995 Aug; 30 Suppl 1:23-31. Deeks S, Volberding P. PMID: 7635914.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    109. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. Blood. 1995 Apr 01; 85(7):1727-35. Kaplan LD, Shiramizu B, Herndier B, Hahn J, Meeker TC, Ng V, Volberding PA, McGrath MS. PMID: 7535586.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    110. The need for additional options in the treatment of human immunodeficiency virus infection. J Infect Dis. 1995 Mar; 171 Suppl 2:S150-4. Volberding P. PMID: 7861020.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. The value of the CD4+ count of 500 cells/microliters. Drugs. 1995; 49 Suppl 1:4-8; discussion 38-40. Volberding P. PMID: 7614901.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    112. Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG). J Acquir Immune Defic Syndr (1988). 1994 Oct; 7(10):1057-63. Fogelman I, Lim L, Bassett R, Volberding P, Fischl MA, Stanley K, Cotton DJ. PMID: 8083823.
      View in: PubMed   Mentions:
    113. Prevalence of oral lesions in symptomatic and asymptomatic HIV patients. Gen Dent. 1994 Sep-Oct; 42(5):446-50. Little JW, Melnick SL, Rhame FS, Balfour HH, Decher L, Rhodus NL, Merry JW, Walker PO, Miller CE, Volberding P. PMID: 7489878.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA. 1994 Aug 10; 272(6):437-42. Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT. PMID: 7913730.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    115. From the Institute of Medicine. JAMA. 1994 Aug 10; 272(6):423. Hardy LM, Haynes BF, Volberding PA. PMID: 8040965.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    116. Educating primary care providers about HIV disease: multidisciplinary interactive mechanisms. Public Health Rep. 1994 May-Jun; 109(3):305-10. Macher A, Goosby E, Barker L, Volberding P, Goldschmidt R, Balano KB, Williams A, Hoenig L, Gould B, Daniels E. PMID: 8190853.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    117. Intermittent therapy. J Acquir Immune Defic Syndr (1988). 1994 May; 7(5):454-6. Volberding PA. PMID: 8158538.
      View in: PubMed   Mentions:
    118. Treatment dilemmas in HIV infection. Hosp Pract (Off Ed). 1994 Apr 15; 29(4):49-54, 59-60. Volberding PA. PMID: 7908297.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    119. Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories. J Infect Dis. 1994 Apr; 169(4):713-21. DeGruttola V, Beckett LA, Coombs RW, Arduino JM, Balfour HH, Rasheed S, Hollinger FB, Fischl MA, Volberding P. PMID: 8133085.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    120. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. N Engl J Med. 1994 Mar 17; 330(11):738-43. Lenderking WR, Gelber RD, Cotton DJ, Cole BF, Goldhirsch A, Volberding PA, Testa MA. PMID: 7906386.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCellsCTClinical Trials
    121. HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship. JAMA. 1994 Feb 02; 271(5):392-3. Volberding PA. PMID: 7904318.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    122. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis. 1994 Jan; 169(1):28-36. Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA. PMID: 7903975.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    123. Zidovudine response relationships in early human immunodeficiency virus infection. Clin Pharmacol Ther. 1993 Nov; 54(5):556-66. Sale M, Sheiner LB, Volberding P, Blaschke TF. PMID: 7900949.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    124. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med. 1993 Oct 15; 119(8):786-93. Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, Henrard DR, Weller S, Corey L. PMID: 8379600.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    125. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med. 1993 May 01; 118(9):674-80. Choi S, Lagakos SW, Schooley RT, Volberding PA. PMID: 8096373.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCellsCTClinical Trials
    126. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1988). 1993 Mar; 6(3):259-64. Fischl MA, Krown SE, O'Boyle KP, Mitsuyasu R, Miles S, Wernz JC, Volberding PA, Kahn J, Groopman JE, Feinberg J. PMID: 8450401.
      View in: PubMed   Mentions:
    127. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group. Arch Intern Med. 1992 Nov; 152(11):2286-92. Koch MA, Volberding PA, Lagakos SW, Booth DK, Pettinelli C, Myers MW. PMID: 1359846.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    128. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med. 1992 Aug 27; 327(9):581-7. Kahn JO, Lagakos SW, Richman DD, Cross A, Pettinelli C, Liou SH, Brown M, Volberding PA, Crumpacker CS, Beall G. PMID: 1353607.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsCTClinical Trials
    129. A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. AIDS Res Hum Retroviruses. 1992 Aug; 8(8):1321-5. Kahn JO, Stites DP, Scillian J, Murcar N, Stryker R, Volberding PA, Naylor PH, Goldstein AL, Sarin PS, Simmon VF. PMID: 1466950.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
    130. Optimal time to initiate anti-HIV therapy: clinical decisions without definitive data. Infect Agents Dis. 1992 Jun; 1(3):163-6. Volberding P. PMID: 1365541.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    131. Epidemiology and the human immunodeficiency virus. Clinical effects of intravenous drug misuse. JAMA. 1992 Mar 25; 267(12):1666-7. Volberding PA. PMID: 1542178.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    132. Management of the complications of human immunodeficiency virus infection. Adv Intern Med. 1992; 37:133-52. Safrin S, Volberding P. PMID: 1557994.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    133. Dronabinol effects on weight in patients with HIV infection. AIDS. 1992 Jan; 6(1):127. Gorter R, Seefried M, Volberding P. PMID: 1311935.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    134. Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complex. Antimicrob Agents Chemother. 1991 Dec; 35(12):2531-7. Gatti G, Kahn JO, Lifson J, Williams R, Turin L, Volberding PA, Gambertoglio JG. PMID: 1810186.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    135. Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex. Antimicrob Agents Chemother. 1991 Dec; 35(12):2580-6. Hodges TL, Kahn JO, Kaplan LD, Groopman JE, Volberding PA, Amman AJ, Arri CJ, Bouvier LM, Mordenti J, Izu AE. PMID: 1810192.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    136. Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. JAMA. 1991 Nov 20; 266(19):2709-12. Lagakos S, Fischl MA, Stein DS, Lim L, Volberding P. PMID: 1942422.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    137. Periodontal status of individuals in early stages of human immunodeficiency virus infection. Community Dent Oral Epidemiol. 1991 Oct; 19(5):281-5. Drinkard CR, Decher L, Little JW, Rhame FS, Balfour HH, Rhodus NL, Merry JW, Walker PO, Miller CE, Volberding PA. PMID: 1742994.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    138. Chemotherapy for AIDS-associated Kaposi's sarcoma. Oncology (Williston Park). 1991 Oct; 5(10):57-63; discussion 64, 67. Kahn J, Northfelt D, Volberding P. PMID: 1838275.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. The management of early human immunodeficiency virus infection. J Thorac Imaging. 1991 Sep; 6(4):6-11. Volberding P. PMID: 1942200.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    140. Drug level monitoring in a double-blind multicenter trial: false-positive zidovudine measurements in AIDS clinical trials group protocol 019. Antimicrob Agents Chemother. 1991 Jun; 35(6):1160-4. Krogstad DJ, Eveland MR, Lim LL, Volberding PA, Sadler BM. PMID: 1929258.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    141. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol. 1991 Jun; 9(6):929-40. Kaplan LD, Kahn JO, Crowe S, Northfelt D, Neville P, Grossberg H, Abrams DI, Tracey J, Mills J, Volberding PA. PMID: 2033429.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    142. Treatment of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am. 1991 Apr; 5(2):297-310. Northfelt DW, Kahn JO, Volberding PA. PMID: 2022595.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    143. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother (1991). 1991 Feb; 10(1):39-50. Evans LM, Itri LM, Campion M, Wyler-Plaut R, Krown SE, Groopman JE, Goldsweig H, Volberding PA, West SB, Mitsuyasu RT. PMID: 1826454.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    144. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial. J Acquir Immune Defic Syndr (1988). 1991; 4(9):839-46. Tappero JW, Berger TG, Kaplan LD, Volberding PA, Kahn JO. PMID: 1895204.
      View in: PubMed   Mentions:
    145. HIV antigen variability in ARC/AIDS. J Acquir Immune Defic Syndr (1988). 1991; 4(9):847-50. Hendrix CW, Volberding PA, Chaisson RE. PMID: 1910082.
      View in: PubMed   Mentions:
    146. Recent advances in the medical management of early HIV disease. J Gen Intern Med. 1991 Jan-Feb; 6(1 Suppl):S7-12. Volberding PA. PMID: 2005480.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    147. Increasing CD8+ T lymphocytes predict subsequent development of intraoral lesions among individuals in the early stages of infection by the human immunodeficiency virus. J Acquir Immune Defic Syndr (1988). 1991; 4(12):1199-207. Melnick SL, Hannan P, Decher L, Little JW, Rhame FS, Balfour HH, Volberding P. PMID: 1682473.
      View in: PubMed   Mentions:
    148. Controversies in the management of HIV-related illnesses. J Gen Intern Med. 1991 Jan-Feb; 6(1 Suppl):S46-55. Cooke M, Libman H, Smith MD, Cooney TG, Hollander H, Makadon HJ, Volberding PA. PMID: 2005478.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    149. The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS. 1990 Dec; 4(12):1197-204. Kahn JO, Kaplan LD, Gambertoglio JG, Bredesen D, Arri CJ, Turin L, Kibort T, Williams RL, Lifson JD, Volberding PA. PMID: 2088398.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    150. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med. 1990 Sep 20; 323(12):769-75. Leoung GS, Feigal DW, Montgomery AB, Corkery K, Wardlaw L, Adams M, Busch D, Gordon S, Jacobson MA, Volberding PA. PMID: 1975426.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCellsCTClinical Trials
    151. Cerebral mass lesions in patients with AIDS. BMJ. 1990 Jul 28; 301(6745):226-8. Montgomery H, Adam A, Dollery CT, Weber J, Volberding P, Griffin B, Scaravilli F. PMID: 2203488.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    152. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med. 1990 Apr 05; 322(14):941-9. Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS. PMID: 1969115.
      View in: PubMed   Mentions: 182     Fields:    Translation:HumansCellsCTClinical Trials
    153. Red cell transfusion therapy for anemia in patients with AIDS and ARC: incidence, associated factors, and outcome. Transfusion. 1990 Feb; 30(2):133-7. Jacobson MA, Peiperl L, Volberding PA, Porteous D, Toy PT, Feigal D. PMID: 2305441.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    154. Rationale for variations in clinical trial design in different HIV disease stages. J Acquir Immune Defic Syndr (1988). 1990; 3 Suppl 2:S40-4. Volberding PA. PMID: 2231301.
      View in: PubMed   Mentions:
    155. Attitudes and opinions toward HIV infection of 1,008 participants to the Vth International Conference on AIDS Montreal, 4-9 June 1989. J Acquir Immune Defic Syndr (1988). 1990; 3(7):742. Tirelli U, Micheluz S, Franceschi S, Serraino D, Lazzarin A, Sacco OL, Clumeck N, Volberding P. PMID: 2352128.
      View in: PubMed   Mentions:
    156. The HIV epidemic: medical and social challenges. Biochim Biophys Acta. 1989 Dec 27; 989(3):227-36. Volberding PA, McCutchan JA. PMID: 2695167.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    157. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA. 1989 Nov 03; 262(17):2405-10. Fischl MA, Richman DD, Causey DM, Grieco MH, Bryson Y, Mildvan D, Laskin OL, Groopman JE, Volberding PA, Schooley RT. PMID: 2677429.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    158. Moving towards a uniform staging for human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol. 1989 Sep; 7(9):1184-5. Volberding PA. PMID: 2769326.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    159. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. J Infect Dis. 1989 Jun; 159(6):1029-36. Jacobson MA, Abrams DI, Volberding PA, Bacchetti P, Wilber J, Chaisson RE, Crowe S, Howard W, Moss A. PMID: 2566637.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    160. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA. 1989 Feb 03; 261(5):719-24. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, Ziegler J, Volberding PA. PMID: 2536124.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    161. Supporting the health care team in caring for patients with AIDS. JAMA. 1989 Feb 03; 261(5):747-8. Volberding P. PMID: 2911172.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    162. Treatment of AIDS and its attendant malignancies. Prog Clin Biol Res. 1989; 288:459-70. Volberding PA, Kaplan LD. PMID: 2654959.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    163. HIV infection as a disease: the medical indications for early diagnosis. J Acquir Immune Defic Syndr (1988). 1989; 2(5):421-5. Volberding P. PMID: 2795447.
      View in: PubMed   Mentions:
    164. Kaposi's sarcoma in AIDS. Immunol Ser. 1989; 44:345-58. Volberding PA. PMID: 2489116.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    165. Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trial. J Acquir Immune Defic Syndr (1988). 1989; 2(3):217-23. Kahn JO, Kaplan LD, Volberding PA, Ziegler JL, Crowe S, Saks SR, Abrams DI. PMID: 2498507.
      View in: PubMed   Mentions:
    166. A phase I/II study of recombinant tumor necrosis factor and recombinant interferon gamma in patients with AIDS-related complex. Biotechnol Ther. 1989-1990; 1(3):229-36. Kaplan LD, Abrams DI, Sherwin SA, Kahn J, Volberding PA. PMID: 2562651.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    167. Providing clinical pharmacy services in an AIDS--oncology ambulatory-care clinic. Am J Hosp Pharm. 1988 Nov; 45(11):2351-4. Wong RJ, Volberding PA. PMID: 2852473.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    168. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial. Arch Intern Med. 1988 Oct; 148(10):2151-3. Chaisson RE, Leuther MD, Allain JP, Nusinoff-Lehrman S, Boone GS, Feigal D, Volberding P. PMID: 3263098.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    169. Zidovudine (AZT): costs and benefits. Br J Hosp Med. 1988 Aug; 40(2):101. Volberding P. PMID: 3139119.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    170. Prolonged pancytopenia due to combined ganciclovir and zidovudine therapy. J Infect Dis. 1988 Aug; 158(2):489-90. Jacobson MA, de Miranda P, Gordon SM, Blum MR, Volberding P, Mills J. PMID: 3261316.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    171. Caring for the patient with AIDS. An integrated approach. Infect Dis Clin North Am. 1988 Jun; 2(2):543-50. Volberding PA. PMID: 3204267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    172. Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr (1988). 1988; 1(1):23-30. Kaplan LD, Hopewell PC, Jaffe H, Goodman PC, Bottles K, Volberding PA. PMID: 3265151.
      View in: PubMed   Mentions:
    173. Treatment of malignant disease in AIDS patients. AIDS. 1988; 2 Suppl 1:S169-75. Volberding P. PMID: 3147666.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    174. Fine-needle aspiration biopsy of patients with acquired immunodeficiency syndrome (AIDS): experience in an outpatient clinic. Ann Intern Med. 1988 Jan; 108(1):42-5. Bottles K, McPhaul LW, Volberding P. PMID: 3337514.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    175. Tumor necrosis factors alpha and beta in acquired immunodeficiency syndrome (AIDS) and aids-related complex. J Clin Immunol. 1987 Nov; 7(6):481-5. Ammann AJ, Palladino MA, Volberding P, Abrams D, Martin NL, Conant M. PMID: 3693521.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    176. Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. JAMA. 1987 Sep 11; 258(10):1347-51. Cheson BD, Levine AM, Mildvan D, Kaplan LD, Wolfe P, Rios A, Groopman JE, Gill P, Volberding PA, Poiesz BJ. PMID: 3650339.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    177. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23; 317(4):192-7. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS. PMID: 3299090.
      View in: PubMed   Mentions: 243     Fields:    Translation:HumansCTClinical Trials
    178. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23; 317(4):185-91. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT. PMID: 3299089.
      View in: PubMed   Mentions: 370     Fields:    Translation:HumansCTClinical Trials
    179. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol. 1987 Jun; 14(2 Suppl 2):43-7. Abrams DI, Volberding PA. PMID: 3589704.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    180. The role of chemotherapy for epidemic Kaposi's sarcoma. Semin Oncol. 1987 Jun; 14(2 Suppl 3):23-6. Volberding PA. PMID: 2440109.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    181. Lack of response to suramin in patients with AIDS and AIDS-related complex. Am J Med. 1987 Mar 23; 82(3 Spec No):615-20. Kaplan LD, Wolfe PR, Volberding PA, Feorino P, Levy JA, Abrams DI, Kiprov D, Wong R, Kaufman L, Gottlieb MS. PMID: 3548350.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    182. Treatment of patients with acquired immunodeficiency syndrome and associated manifestations. JAMA. 1987 Mar 13; 257(10):1367-74. Kaplan LD, Wofsy CB, Volberding PA. PMID: 3546745.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    183. Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A). Cancer. 1987 Feb 01; 59(3 Suppl):620-5. Volberding PA, Mitsuyasu RT, Golando JP, Spiegel RJ. PMID: 3492260.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    184. Therapy of acquired immune deficiency syndrome with recombinant interleukin-2. AIDS Res Hum Retroviruses. 1987; 3(2):115-24. Volberding P, Moody DJ, Beardslee D, Bradley EC, Wofsy CB. PMID: 3113462.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    185. Exposure to hair dyes and polychlorinated dibenzo-p-dioxins in AIDS patients with Kaposi sarcoma: an epidemiological investigation. Cancer Detect Prev Suppl. 1987; 1:567-70. Hardell L, Moss A, Osmond D, Volberding P. PMID: 3480068.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    186. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine. N Engl J Med. 1986 Dec 18; 315(25):1610-1. Chaisson RE, Allain JP, Leuther M, Volberding PA. PMID: 3466034.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    187. AIDS-related benign lymphadenopathy and malignant lymphoma: clinical aspects and virologic interactions. AIDS Res. 1986 Dec; 2 Suppl 1:S131-40. Abrams DI, Kaplan LD, McGrath MS, Volberding PA. PMID: 3828009.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    188. Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis. 1986 Nov; 134(5):891-6. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. PMID: 3777686.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    189. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol. 1986 Sep; 13(3 Suppl 2):43-7. Abrams DI, Volberding PA. PMID: 3532335.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    190. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep. 1986 Sep; 70(9):1121-2. Kaplan L, Abrams D, Volberding P. PMID: 3742492.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    191. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med. 1986 Jul; 105(1):37-44. Wharton JM, Coleman DL, Wofsy CB, Luce JM, Blumenfeld W, Hadley WK, Ingram-Drake L, Volberding PA, Hopewell PC. PMID: 3521428.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCTClinical Trials
    192. Kaposi's sarcoma and the acquired immunodeficiency syndrome. Med Clin North Am. 1986 May; 70(3):665-75. Volberding PA. PMID: 3007893.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    193. Routine care and psychosocial support of the patient with the acquired immunodeficiency syndrome. Med Clin North Am. 1986 May; 70(3):707-20. Abrams DI, Dilley JW, Maxey LM, Volberding PA. PMID: 3959664.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    194. Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis. 1986 Apr; 153(4):736-42. Groopman JE, Chen FW, Hope JA, Andrews JM, Swift RL, Benton CV, Sullivan JL, Volberding PA, Sites DP, Landesman S. PMID: 3005434.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    195. Preferences of homosexual men with AIDS for life-sustaining treatment. N Engl J Med. 1986 Feb 13; 314(7):457-60. Steinbrook R, Lo B, Moulton J, Saika G, Hollander H, Volberding PA. PMID: 3945276.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    196. Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med. 1986 Jan; 104(1):47-50. Abrams DI, Kiprov DD, Goedert JJ, Sarngadharan MG, Gallo RC, Volberding PA. PMID: 3000249.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    197. Recombinant interferon alpha in the treatment of acquired immune deficiency syndrome-related Kaposi's sarcoma. Semin Oncol. 1985 Dec; 12(4 Suppl 5):2-6. Volberding PA, Mitsuyasu R. PMID: 3909416.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    198. The clinical spectrum of the acquired immunodeficiency syndrome: implications for comprehensive patient care. Ann Intern Med. 1985 Nov; 103(5):729-33. Volberding PA. PMID: 4051349.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    199. Ethical dilemmas in caring for patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov; 103(5):787-90. Steinbrook R, Lo B, Tirpack J, Dilley JW, Volberding PA. PMID: 4051355.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    200. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Sep; 103(3):335-8. Volberding PA, Abrams DI, Conant M, Kaslow K, Vranizan K, Ziegler J. PMID: 4026082.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    201. Failure (and danger) of mitozantrone in AIDS-related Kaposi's sarcoma. Lancet. 1985 Aug 17; 2(8451):396. Kaplan L, Volberding PA. PMID: 2862556.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    202. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci U S A. 1985 Aug; 82(16):5535-9. Kaminsky LS, McHugh T, Stites D, Volberding P, Henle G, Henle W, Levy JA. PMID: 2991932.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    203. Clinical care and research in AIDS. Hastings Cent Rep. 1985 Aug; 15(4):suppl 16-8. Volberding P, Abrams D. PMID: 4055346.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    204. Impaired mononuclear-cell proliferation in patients with the acquired immune deficiency syndrome results from abnormalities of both T lymphocytes and adherent mononuclear cells. J Clin Immunol. 1985 Jul; 5(4):239-45. Shannon K, Cowan MJ, Ball E, Abrams D, Volberding P, Ammann AJ. PMID: 3876352.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    205. Incidence of the acquired immunodeficiency syndrome in San Francisco, 1980-1983. J Infect Dis. 1985 Jul; 152(1):152-61. Moss AR, Bacchetti P, Osmond D, Dritz S, Abrams D, Conant M, Volberding P, Ziegler J. PMID: 3874250.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    206. Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS). Histological and clinical comparison with Whipple's disease. Dig Dis Sci. 1985 May; 30(5):497-504. Roth RI, Owen RL, Keren DF, Volberding PA. PMID: 2580679.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    207. Findings in psychiatric consultations with patients with acquired immune deficiency syndrome. Am J Psychiatry. 1985 Jan; 142(1):82-6. Dilley JW, Ochitill HN, Perl M, Volberding PA. PMID: 3966588.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    208. Incidence of the acquired immunodeficiency syndrome in San Francisco. Front Radiat Ther Oncol. 1985; 19:14-20. Moss AR, Abrams D, Conant M, Volberding P. PMID: 3979822.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    209. Lymphadenopathy: end-point prodrome? Update of a 36-month prospective study. Adv Exp Med Biol. 1985; 187:73-84. Abrams DI, Mess T, Volberding PA. PMID: 2994422.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    210. Interferon and interleukin-2 therapy of Kaposi's sarcoma. Adv Exp Med Biol. 1985; 187:151-7. Volberding PA, Wofsy CB, Abrams DI. PMID: 3875980.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    211. The problem of Kaposi's sarcoma in AIDS. Front Radiat Ther Oncol. 1985; 19:91-8. Volberding PA. PMID: 3884452.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    212. Isolated thrombocytopenia in homosexual men--longitudinal follow-up. Adv Exp Med Biol. 1985; 187:117-22. Abrams DI, Kiprov DD, Volberding PA. PMID: 3929576.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    213. Hepatitis B virus (HBV) DNA in leucocytes in acquired immune deficiency syndrome (AIDS). Cytobios. 1985; 44(176):119-28. Lie-Injo LE, Volberding P, Golden JA, Herrera AR. PMID: 3004832.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    214. Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst. 1984 Dec; 73(6):1281-4. Moss AR, McCallum G, Volberding PA, Bacchetti P, Dritz S. PMID: 6334770.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    215. Phase II trial of 4'-epi-doxorubicin in metastatic melanoma. Cancer Treat Rep. 1984 Dec; 68(12):1509-10. Torti FM, Porzig KJ, Gandara DR, Volberding P, Mitchell E, Meyers FJ, Kohler M, Gribble M. PMID: 6595059.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    216. A methodology for the analysis of the preneoplastic antigen. Carcinogenesis. 1984 Nov; 5(11):1467-73. Hammock BD, Loury DN, Moody DE, Ruebner B, Baselt R, Milam KM, Volberding P, Ketterman A, Talcott R. PMID: 6488472.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    217. Failure of isotretinoin in Kaposi's sarcoma. Lancet. 1984 Sep 15; 2(8403):641. Ziegler JL, Volberding PA, Itri LM. PMID: 6147674.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    218. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 30; 311(9):565-70. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE. PMID: 6611504.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCells
    219. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA. 1984 Mar 16; 251(11):1447-9. Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. PMID: 6608011.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    220. Therapy of Kaposi's sarcoma in AIDS. Semin Oncol. 1984 Mar; 11(1):60-7. Volberding P. PMID: 6372100.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    221. Kaposi sarcoma and lymphadenopathy syndrome: limitations of abdominal CT in acquired immunodeficiency syndrome. Radiology. 1984 Feb; 150(2):479-83. Moon KL, Federle MP, Abrams DI, Volberding P, Lewis BJ. PMID: 6691105.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    222. High-grade non-Hodgkin's lymphoma in patients with AIDS. Ann N Y Acad Sci. 1984; 437:412-9. Ziegler JL, Bragg K, Abrams D, Beckstead J, Cogan M, Volberding P, Baer D, Wilkinson L, Rosenbaum E, Grant K. PMID: 6598309.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    223. Lymphadenopathy: endpoint or prodrome? Update of a 24-month prospective study. Ann N Y Acad Sci. 1984; 437:207-15. Abrams DI, Lewis BJ, Volberding PA. PMID: 6335951.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    224. Hematologic manifestations in homosexual men with Kaposi's sarcoma. Am J Clin Pathol. 1984 Jan; 81(1):13-8. Abrams DI, Chinn EK, Lewis BJ, Volberding PA, Conant MA, Townsend RM. PMID: 6704205.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    225. The AIDS epidemic: continental drift. Nature. 1984 Jan 19-25; 307(5948):211-2. Groopman JE, Volberding PA. PMID: 6694724.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    226. Alpha interferon therapy of Kaposi's sarcoma in AIDS. Ann N Y Acad Sci. 1984; 437:439-46. Volberding P, Valero R, Rothman J, Gee G. PMID: 6398652.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    227. Oral manifestations of tumor and opportunistic infections in the acquired immunodeficiency syndrome (AIDS): findings in 53 homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol. 1983 Nov; 56(5):491-4. Lozada F, Silverman S, Migliorati CA, Conant MA, Volberding PA. PMID: 6580594.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    228. Disseminated Kaposi's sarcoma in male homosexuals. J Am Podiatry Assoc. 1983 Aug; 73(8):413-7. Rubenstein SA, Jenkin WM, Conant MA, Volberding PA. PMID: 6619493.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    229. Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. N Engl J Med. 1983 Jun 23; 308(25):1535-6. Mitsuyasu R, Groopman J, Volberding P. PMID: 6222258.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    230. Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol. 1983 Jun; 27(3):315-25. Ammann AJ, Abrams D, Conant M, Chudwin D, Cowan M, Volberding P, Lewis B, Casavant C. PMID: 6223758.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    231. AIDS in the "gay" areas of San Francisco. Lancet. 1983 Apr 23; 1(8330):923-4. Moss AR, Bacchetti P, Gorman M, Dritz S, Conant M, Abrams DI, Volberding P, Ziegler J. PMID: 6132235.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    232. Chemotherapy in advanced Kaposi's sarcoma. Implications for current cases in homosexual men. Am J Med. 1983 Apr; 74(4):652-6. Volberding P, Conant MA, Stricker RB, Lewis BJ. PMID: 6837590.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    233. Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet. 1982 Jul 17; 2(8290):125-7. Drew WL, Conant MA, Miner RC, Huang ES, Ziegler JL, Groundwater JR, Gullett JH, Volberding P, Abrams DI, Mintz L. PMID: 6123839.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    234. Squamous cell carcinoma in sexual partner of Kaposi sarcoma patient. Lancet. 1982 Jan 30; 1(8266):286. Conant MA, Volberding P, Fletcher V, Lozada FI, Silverman S. PMID: 6120304.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    235. Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate. Cancer Chemother Pharmacol. 1982; 9(1):17-21. Volberding PA, Friedman MA, Resser KJ, Phillips TL. PMID: 7139849.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    236. Genetic analysis of induction of anti-polyadenylic acid antibodies and xenotropic type-C viruses. Clin Exp Immunol. 1981 Jun; 44(3):615-9. Fischbach M, Volberding P, Talal N, Levy J. PMID: 6276056.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    237. Therapy of hepatocellular cancer with combined intrahepatic arterial chemotherapy and whole liver irradiation. Ann Acad Med Singapore. 1980 Apr; 9(2):260-3. Friedman MA, Volberding PA, Cassidy MJ, Resser KJ, Wasserman TH, Phillips TL. PMID: 6252817.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    238. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1885-8. Friedman MA, Volberding PA, Cassidy MJ, Resser KJ, Wasserman TH, Phillips TL. PMID: 230895.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    239. Avian tumour virus interactions with chicken fibroblast membranes: partial characterization of initial attachment site activity. J Gen Virol. 1977 Nov; 37(2):385-98. Moldow CF, Volberding P, McGrath M, Lee JL. PMID: 200712.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    Paul's Networks
    Concepts (653)
    Derived automatically from this person's publications.
    _
    Co-Authors (72)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _